Disclosures for "Safety, Tolerability, Pharmacokinetics, and Efficacy of Fenfluramine in Combination With Cannabidiol: Results From a Phase 1 Study"
-
Dr. Zhang-Roper has received personal compensation for serving as an employee of UCB.
-
Dr. Mittur has received personal compensation for serving as an employee of UCB. Dr. Mittur has stock in UCB. Dr. Mittur has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Boyd has received personal compensation for serving as an employee of UCB Biosciences. Dr. Boyd has stock in UCB Biosciences. Dr. Boyd has received intellectual property interests from a discovery or technology relating to health care.
-
Melanie LANGLOIS has received personal compensation for serving as an employee of UCB Pharma. Melanie LANGLOIS has stock in UCB Pharma.
-
Dr. Evans has received personal compensation for serving as an employee of UCB Biosciences. Dr. Evans has stock in UCB Biosciences.
-
Dr. Morita has received personal compensation for serving as an employee of UCB Biosciences, Inc. Dr. Morita has stock in UCB, Inc.
-
Author has nothing to disclose